HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Janssen licenses rights to Eisai's proton pump inhibitor

Executive Summary

J&J's Belgian subsidiary Janssen will co-promote Japanese pharmaceutical company Eisai's proton pump inhibitor, Pariet (rabeprazole), in the US, UK, Germany, and France.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register